Roger Barker, MD, PhD

Roger Barker, BA, MBBS, MRCP, PhD, FMedSci is the Professor of Clinical Neuroscience at the University of Cambridge and Consultant Neurologist at the Addenbrooke’s Hospital. He is a principal investigator in the Cambridge Stem Cell Institute. He is the Lead Academic Scientist of: Cambridge Drug Discovery Institute and John van Geest Centre for Brain Repair and chair of Neurodegeneration at LifeArc. He became the President of the World Parkinson Coalition in 2023.

His research seeks to better characterize the clinical heterogeneity of Parkinson’s disease and its basis. This has helped in the delivery of new therapies to subtypes of PD patients including leading on novel gene and cell-based therapies. He has planned and undertaken several experimental clinical trials, including a two neural transplant trials in PD (TRANSEURO and new STEM-PD trial).